PD-L1 Expression Heterogeneity in NSCLC: Accuracy and Reliability of Using Primary Lung Tumour Versus Metastatic Lymph Node Deposits

被引：0

作者：

Haragan, A. K. ^{[1
]}

Field, J. K. ^{[2
]}

Davies, M. P. A. ^{[2
]}

Escriu, C. ^{[3
]}

Gruver, A. ^{[4
]}

Gosney, J. R. ^{[1
]}

机构：

[1] Univ Liverpool, Royal Liverpool Univ Hosp, Liverpool, Merseyside, England

[2] Univ Liverpool, Liverpool, Merseyside, England

[3] Clatterbridge Oncol Ctr, Birkenhead, Merseyside, England

[4] Eli Lily & Co, Indianapolis, IN USA

来源：

JOURNAL OF PATHOLOGY | 2019年 / 248卷

基金：

英国医学研究理事会;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S11 / S11

页数：1

共 50 条

[41] PD-L1 expression on NSCLC lung tumors is affected by the presence of COPD.
Tine, Mariaenrica
Semenzato, Umberto
Ferrara, Martina Maria
Frasson, Giulia
Biondini, Davide
Damin, Marco
Pezzuto, Federica
Calabrese, Fiorella
Baraldo, Simonetta
Cosio, Manuel G.
Saetta, Marina
Ferrara, Martina Maria
EUROPEAN RESPIRATORY JOURNAL, 2023, 62
[42] The comparison of PD-L1 expression in primary with metastatic sites in gastric cancer
Toihata, Tasuku
Iwatsuki, Masaaki
Yamashita, Kouhei
Koga, Yuki
Kuroda, Daisuke
Hiyoshi, Yukiharu
Baba, Yoshifumi
Miyamoto, Yuji
Yoshida, Naoya
Baba, Hideo
CANCER SCIENCE, 2018, 109 : 1058 - 1058
[43] Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
Yuan, Chenxi
Liu, Zhaoyun
Yu, Qian
Wang, Xinzhao
Bian, Mengxue
Yu, Zhiyong
Yu, Jinming
SCIENTIFIC REPORTS, 2019, 9 (1)
[44] Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
Chenxi Yuan
Zhaoyun Liu
Qian Yu
Xinzhao Wang
Mengxue Bian
Zhiyong Yu
Jinming Yu
Scientific Reports, 9
[45] The Value of PD-L1 Expression in metastatic Lymph Nodes of Advanced Non-Small Cell Lung Cancer
Yang, Haitang
Hall, Sean R. R.
Yao, Feng
CHEST, 2020, 158 (04) : 1785 - 1787
[46] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
Munari, Enrico
Zamboni, Giuseppe
Marconi, Marcella
Sommaggio, Marco
Brunelli, Matteo
Martignoni, Guido
Netto, George J.
Moretta, Francesca
Mingari, Maria Cristina
Salgarello, Matteo
Terzi, Alberto
Picece, Vincenzo
Pomari, Carlo
Lunardi, Gianluigi
Cavazza, Alberto
Rossi, Giulio
Moretta, Lorenzo
Bogina, Giuseppe
ONCOTARGET, 2017, 8 (52): : 90123 - 90131
[47] Comparison of PD-L1 mRNA expression measured with the CheckPointTyper® assay with PD-L1 protein expression assessed with immunohistochemistry (IHC) in lung cancer (NSCLC)
Erber, R.
Stoehr, R.
Herlein, S.
Fuchs, F.
Veltrup, E.
Wirtz, R.
Hartmann, A.
VIRCHOWS ARCHIV, 2017, 471 : S102 - S102
[48] PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma
Kung, Felix F.
Arias-Mejias, Suzette M.
Quattrocchi, Enrica
Sominidi-Damodaran, Sindhuja
Bridges, Alina G.
Lehman, Julia S.
Weaver, Amy L.
Meves, Alexander
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (11) : 2301 - +
[49] PD-1, PD-L1, and BIM as predictors of sentinel lymph node metastasis in primary cutaneous melanoma
Meves, Alexander
Kung, Felix
Sominidi-Damodaran, Sindhuja
Weaver, Amy L.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB67 - AB67
[50] Digital pathology predicts PD-L1 expression in metastatic NSCLC patients treated with immunotherapy
Prelaj, A.
Sacco, M.
Miskovic, V.
Lorenzini, D.
Trovo, F.
Zec, A.
Roisman, L. C.
Provenzano, L.
Proto, C.
Spagnoletti, A.
Silvestri, C.
Meya, A.
Pedrocchi, A.
Sarris, E.
Felip, E.
Reck, M.
De Braud, F. G. M.
Lo Russo, G.
Pearson, A. T.
Garassino, M. C.
ANNALS OF ONCOLOGY, 2024, 35 : S840 - S841

← 1 2 3 4 5 →